| |
|
|
Session 96
Poster Presentations Metabolic and Other Complications in Pediatric HIV Infection Thursday 1:30 - 3:30 pm Hall B |
| 770 | Long-term Growth and Developmental Outcomes in Children with in Utero Cocaine and Opiate Exposure Born to HIV-infected Women E. Handelsman*1, B. Thompson2, D. Li2, C. Macmillan3, V. Smeriglio4, C. Mellins5, J. Moye6, M. Paul7, E. Matzen8, E. Cooper9 1State Univ of New YorkDownstate, Brooklyn; 2Clinical Trials and Surveys Corporation, Baltimore, MD; 3Univ of Illinois at Chicago; 4Natl Inst of Drug Abuse; 5Columbia University, New York, NY; 6Natl Inst of Child Hlth and Human Development; 7Baylor Coll of Med, Houston, TX; 8NIAID, NIH, Bethesda, MD; and 9Boston Univ Med Ctr, MA |
| 771 | Placenta and Cord Blood Mitochondrial DNA Toxicity in HIV-infected Women Receiving Nucleoside Reverse Transcriptase Inhibitors During Pregnancy B. Shiramizu*1, K. Shikuma2, L. Kamemoto1, M. Gerschenson1, G. Erdem1, M. Pinti3, A. Cossarizza3, C. Shikuma1 1Univ of Hawaii, Honolulu; 2Univ of Southern California, Los Angeles; and 3Univ of Modena and Reggio Emilia, Italy |
| 772 | High Prevalence of Metabolic Abnormalities in HIV-infected Children Treated with HAART J. T. Ramos*, L. García, P. Rojo, C. Ruano, P. Carreño, J. Ruiz-Contreras, F. Hawkins Hosp 12 de Oct, Madrid, Spain |
| 773 | Prevalence of Hypercholesterolemia and Associated Risk Factors Among Perinatally HIV-infected Children (4 J. Farley*1, P. Gona2, M. Crain3, J. Cervia4, J. Lindsey2, J. Oleske5 1Univ of Maryland Sch of Med, Baltimore; 2Harvard Sch of Public Hlth, Boston, MA; 3Univ of Alabama at Birmingham Sch of Medicine; 4Long Island Jewish Med Ctr, New Hyde Park, NY; and 5Univ of Med and Dentistry of New Jersey, Newark |
| 774 | Fat Redistribution and Metabolic Abnormalities in HIV-infected Children and Adolescents in Europe A. Vigano1, C. Thorne*2, Italian Register on HIV in Children3, European Collaborative Study2 1Hosp L Sacco, Milan, Italy; 2Inst of Child Hlth, London, UK; and 3Italy |
| 775 | Body Composition and Biochemical Changes in Children Starting or Switching Combination Antiretroviral Chemotherapy C. Chantry*1, J. Cervia2, M. Hughes3, K. Patra3, J. Hodge4, J. Moye5, the PACTG Protocol 1010 Study Team6 1Univ of California at Davis, Sacramento; 2Long Island Jewish Med Ctr, New York, NY; 3Harvard Sch of Public Hlth, Boston, MA; 4Frontier Sci and Tech Res Fndn, Buffalo, NY; 5Natl Inst of Hlth, NICHD, Bethesda, MD; and 6Pediatric AIDS Clin Trials Group, Silver Spring MD |
| 776 | Impaired GH Secretion Corrolates with Increased Visceral Adiposity and Hyperinsulinemia in HAART-treated Children A. Vigano*1, S. Mora2, P. Brambilla1, L. Monti2, L. Schneider1, P. Manzoni1 1Paediatric Clin L Sacco Hosp, Milan, Italy and 2IRCCS Hosp San Raffaele, Milan, Italy |
| 777 | Hyperlactatemia in Children Exposed to Antiretrovirals and its Relation with Lipodystrophy Syndrome in HIV-infected HAART-treated Pediatric Patients C. Fortuny*, A. Noguera, M. A. Vilaseca, R. Artuch, M. C. Muñoz, C. Sierra, J. Pou, R. Jimenez Hosp St Joan de Déu, Barcelona, Spain |
| 778 | Effect of HAART on Bone Density in HIV-infected Children H. Schwarzwald*1,2, K. J. Ellis1,2, D. L. Evans1,2, N. E. Kline1,2, A. McMeans1,2, M. W. Kline1,2 1Baylor Coll of Med, Houston, TX and 2Texas Children's Hosp Houston |
| 779 | The Effect of Calcium and Vitamin D on Bone Mineral Density in HIV-infected Children with Osteoporosis G. A. McComsey*1,2, E. G. Leonard1 1Rainbow Babies and Children's Hosp, Cleveland, OH and 2Ctr for AIDS Res of Case Western Reserve Univ, Cleveland, OH |
| 780 | Measles and Rubella Antibodies in Fully Immunized HIV-1 Infected Children: Response to an Extra MMR Dose under HAART D. Takano*, P. Russo, A. Rufino, R. Succi, L. Weckx, M. Isabel de Moraes-Pinto Fed Univ of Sao Paulo, Brazil |
| 781 | Psychiatric Hospitalizations Among HIV-infected Children and Youth S. Nachman*1, D. M. Gaughan2, K. Malee3, J. M. Oleske4, M. D. Hughes2 1State Univ of New York, Stony Brook; 2Harvard Sch of Public Hlth, Boston, MA; 3Chicago Children's Mem Hosp, IL; and 4Univ of Med and Dentistry of New Jersey, NJ Med Sch, Newark |
| 782 | Risk of Birth Defects Associated with Nelfinavir Exposure during Pregnancy S. D. Conner*1, D. L. Covington2, P. A. Doi2, J. Swinson2, E. M. Daniels1 1Agouron Pharmaceuticals, Inc, a Pfizer Co, San Diego, CA and 2PharmaRes Corp, Wilmington, NC |